ストックスクリーナーアプリを入手
3.34
1.52%
0.05
アフターアワーズ：
3.30
-0.04
-1.20%
Briacell Therapeutics Corp (BCTX) 最新ニュース
(BCT) Pivots Trading Plans and Risk Controls (BCT:CA) - news.stocktradersdaily.com
Stocks In Play - Baystreet.ca
Stocks in play: BriaCell Therapeutics Corp. - The Globe and Mail
BriaCell Therapeutics Corp. - Baystreet.ca
BriaCell Therapeutics Schedules Virtual Investor Presentations for June 2025 - TipRanks
BriaCell Announces Virtual Investor Presentations on Thursday, June 12 and Thursday, June 26 | BCTX Stock News - GuruFocus
BriaCell Announces Virtual Investor Presentations on Thursday, June 12 and Thursday, June 26 - GlobeNewswire
BriaCell’s Bria-IMT Shows Strong Survival & Benefit in Advanced Breast Cancer - Insider Monkey
Stocks In Play: BriaCell Therapeutics Corp. By Baystreet.ca - Investing.com Canada
BriaCell Reports Promising Survival Data in Metastatic Breast Cancer Studies - TipRanks
BriaCell (BCTX) Shares Clinical Advancements at ASCO Meeting | B - GuruFocus
BriaCell Reports Robust Overall Survival and Clinical Benefit Data at ASCO 2025 - GlobeNewswire
Clinical Trial Success: BriaCell's Breast Cancer Treatment Outperforms FDA-Approved Therapies at ASCO 2025 - Stock Titan
(BCT) Stock Market Analysis (BCT:CA) - news.stocktradersdaily.com
(BCT) Market Dynamics and Trading Signals (BCT:CA) - news.stocktradersdaily.com
BriaCell Therapeutics (NASDAQ:BCTX) Stock Price Up 1.6% – Should You Buy? - Defense World
When (BCT) Moves Investors should Listen (BCT:CA) - news.stocktradersdaily.com
BriaCell Therapeutics Corp - Baystreet.ca
Cardiol Therapeutics Inc. - Baystreet.ca
BriaCell advances cancer treatment with Bria-OTS in clinical study By Investing.com - Investing.com South Africa
BriaCell Bria-OTS? Phase 1/2 Study Clears Safety Evaluation; Doses First Patient in Combination with Checkpoint Inhibitor - marketscreener.com
BriaCell advances cancer treatment with Bria-OTS in clinical study - Investing.com
BriaCell Advances Bria-OTS in Cancer Immunotherapy with New Study Phase - TipRanks
BriaCell (BCTX): Advances in Cancer Treatment with Bria-OTS | BC - GuruFocus
BriaCell Bria-OTS™ Phase 1/2 Study Clears Safety Evaluation; Dos - GuruFocus
BriaCell (BCTX): Advances in Cancer Treatment with Bria-OTS | BCTX Stock News - GuruFocus
BriaCell Bria-OTS™ Phase 1/2 Study Clears Safety - GlobeNewswire
BriaCell's Breast Cancer Immunotherapy Shows Early Success: Patient's Lung Metastasis Completely Resolved - Stock Titan
(BCT) Advanced Equity Analysis (BCT:CA) - news.stocktradersdaily.com
BriaCell Therapeutics: Stocks Undervalued by Analyst Consensus on TSX (BCT) - The Globe and Mail
BriaCell (BCTX) Showcases Promising Data at ASCO 2025 | BCTX Sto - GuruFocus
BriaCell Therapeutics Reports Promising Phase 2 Results for Metastatic Breast Cancer Treatment - TipRanks
BriaCell to Showcase Survival and Clinical Benefit Data at ASCO Meeting Next Week - marketscreener.com
BriaCell (BCTX) Showcases Promising Data at ASCO 2025 | BCTX Stock News - GuruFocus
BriaCell Abstracts Showcase Positive Survival and Clinical Benefit Data at ASCO 2025 - The Manila Times
‘Don’t Doubt UNH Yet,’ Top JPMorgan Analyst Defends UnitedHealth Stock amid Recent Volatility - The Globe and Mail
Breakthrough: BriaCell's New Breast Cancer Drug Shows 13.4-Month Survival Rate, Beating Standard Therapies - Stock Titan
OpenAI CEO Sam Altman Admits Even They Are ‘a Little Bit Scared’ of What They’re Building—But That’s a Good Thing - The Globe and Mail
Stock Market News Today, 5/22/25 – Futures Flat, Post Deficit-Fear-Driven Sell-Off - The Globe and Mail
Moderna Stock Looks Ripe for a Short Squeeze - The Globe and Mail
(BCT) Trading Signals (BCT:CA) - news.stocktradersdaily.com
BriaCell CEO Letter to Shareholders | BCTX Stock News - GuruFocus
BriaCell (BCTX) Reports Promising Advances in Cancer Treatment Studies | BCTX Stock News - GuruFocus
BriaCell Therapeutics Advances in Cancer Immunotherapy with Promising Clinical Results - TipRanks
Briacell Therapeutics CorpBria-Imt Receives FDA Fast Track Designation For Phase 3 Study - marketscreener.com
BriaCell CEO Letter to Shareholders - GlobeNewswire
Clinical Trial Breakthrough: BriaCell's Breast Cancer Therapy Shows 83% Success Rate, Surpassing Current Standard - Stock Titan
Public market insider buying at CGI (GIB) - The Globe and Mail
BriaCell Therapeutics (OTCMKTS:BCTXF) Stock Price Up 0.7% – Here’s Why - Defense World
BriaCell (BCTX) Reports Promising Advances in Cancer Treatment S - GuruFocus
Cisco Systems: A Safe Investment or a Stagnant Giant? - The Globe and Mail
(BCT) On The My Stocks Page (BCT:CA) - news.stocktradersdaily.com
BriaCell Therapeutics (CVE:BCT) Shares Down 3.8% – Here’s Why - Defense World
(BCT) Comprehensive Trading Strategy Report (BCT:CA) - news.stocktradersdaily.com
WonderFi Jumps Over 35% on Robinhood Acquisition News - The Globe and Mail
HighPeak Energy, Inc. Announces First Quarter 2025 Financial and Operating Results - The Globe and Mail
(BCT) Risk-Controlled Trading Report (BCT:CA) - news.stocktradersdaily.com
Why Are Investors Talking About Roblox Stock? - The Globe and Mail
(BCT) Trading Advice (BCT:CA) - news.stocktradersdaily.com
2 Cash-Producing Stocks to Keep an Eye On and 1 to Avoid - The Globe and Mail
(BCT) Investment Performance Report (BCT:CA) - news.stocktradersdaily.com
New Cancer Treatments Spark Hope as Traditional Funding Faces Uncertainty - PR Newswire
BriaCell (BCTX) Highlights Promising Biomarkers in Metastatic Br - GuruFocus
0.86%
1.24%
大文字化:
|
ボリューム (24 時間):